Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centrus Energy Corp (LEU) vs Smith & Nephew plc (SNN) Price & Performance

Centrus Energy CorpTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Centrus Energy Corp vs Smith & Nephew plc — how do they compare? Centrus Energy Corp trades at $185.25 (market cap $3.77B), while Smith & Nephew plc trades at $29.68 (market cap $12.54B). The key difference: Smith & Nephew plc is far larger — about 3.3× Centrus Energy Corp's market cap, and Smith & Nephew plc pays a 2.65% dividend while Centrus Energy Corp pays none. Which is the better fit depends on your goals.

LEUSNN
Market Cap
$3.77B$12.54B
Sector
EnergyHealth
52-Week High
$436.00$38.70
52-Week Low
$146.61$28.73
Enterprise Value
$3.08B$15.57B
Dividend Yield
2.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centrus Energy Corp

Centrus Energy (LEU) trades at $189.03, down 0.16% on the day, with a bullish technical signal supported by moving averages. The company reported Q2 2026 revenue of $176.1 million, beating expectations, but net income declined to $16.8 million from $28.9 million year-over-year due to higher costs. Recent developments include a $900 million DOE contract and a HALEU supply agreement with X-energy, positioning Centrus as a key player in the nuclear fuel supply chain with a $4.5 billion backlog.

The outlook for LEU is positive given its strategic role in nuclear energy expansion and strong institutional support, but risks include margin compression and execution challenges. Analysts maintain a buy consensus with a $228.50 price target, representing 21% upside potential from current levels.

Smith & Nephew plc

Smith & Nephew (SNN) trades at $30.08, down 0.1% with bearish technical signals. The company reported mixed Q2 2026 results with revenue growth below expectations, leading to a reduced full-year outlook. Fundamentals show strong profitability with 10.1% net margin and improving cash flow trends, though recent earnings misses have tempered sentiment.

Outlook remains cautious with analyst consensus at Hold (65% of coverage). Near-term risks include U.S. orthopedics weakness and competitive pressures, offset by robotics innovation and value-based care expansion. The stock offers stable fundamentals but faces execution challenges in key markets.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Centrus Energy Corp

Centrus Energy is a leading supplier of nuclear fuel and services for the global power industry. It specializes in supplying low-enriched uranium and developing next-generation fuels for advanced nuclear reactors.

Read more on LEU

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN